Literature DB >> 21348959

Clinical translational science 2020: disruptive innovation redefines the discovery-application enterprise.

Scott A Waldman1, Andre Terzic.   

Abstract

Mesh：

Year:  2011        PMID： 21348959      PMCID： PMC5439842          DOI： 10.1111/j.1752-8062.2011.00261.x

Source DB:  PubMed          Journal:  Clin Transl Sci        ISSN： 1752-8054            Impact factor:   4.689


× No keyword cloud information.
  19 in total

1.  Molecular diagnostics. At the nexus of individualized medicine, health care delivery, and public policy.

Authors:  Scott A Waldman; Andre Terzic
Journal:  Clin Transl Sci       Date:  2009-02       Impact factor: 4.689

2.  Experimental therapeutics: a paradigm for personalized medicine.

Authors:  Scott A Waldman; Walter K Kraft; Timothy J Nelson; Andre Terzic
Journal:  Clin Transl Sci       Date:  2009-12       Impact factor: 4.689

3.  Molecular therapeutics from knowledge to delivery.

Authors:  S A Waldman; A Terzic
Journal:  Clin Pharmacol Ther       Date:  2010-06       Impact factor: 6.875

4.  On board with the Cures Acceleration Network.

Authors:  Elizabeth G Nabel
Journal:  Sci Transl Med       Date:  2010-05-19       Impact factor: 17.956

5.  Training translators for smart drug discovery.

Authors:  Carsten Skarke; Garret A FitzGerald
Journal:  Sci Transl Med       Date:  2010-04-07       Impact factor: 17.956

6.  The path to personalized medicine.

Authors:  Margaret A Hamburg; Francis S Collins
Journal:  N Engl J Med       Date:  2010-06-15       Impact factor: 91.245

7.  Patient-Centered Outcomes Research Institute: the intersection of science and health care.

Authors:  Carolyn Clancy; Francis S Collins
Journal:  Sci Transl Med       Date:  2010-06-23       Impact factor: 17.956

8.  Translational medicine: path to personalized and public health.

Authors:  Andre Terzic; Scott A Waldman
Journal:  Biomark Med       Date:  2010-12       Impact factor: 2.851

9.  The bridge between lab and clinic. Interview by Meredith Wadman.

Authors:  Francis Collins
Journal:  Nature       Date:  2010-12-16       Impact factor: 49.962

10.  Molecular therapy drives patient-centric health care paradigms.

Authors:  Scott A Waldman; Andre Terzic
Journal:  Clin Transl Sci       Date:  2010-08       Impact factor: 4.689
View more
  4 in total

1.  Chronic diseases: the emerging pandemic.

Authors:  Andre Terzic; Scott Waldman
Journal:  Clin Transl Sci       Date:  2011-06       Impact factor: 4.689

2.  Shaping a new generation of Hispanic clinical and translational researchers addressing minority health and health disparities.

Authors:  Estela S Estapé; Barbara Segarra; Adriana Báez; Aracelis Huertas; Clemente Díaz; Walter R Frontera
Journal:  P R Health Sci J       Date:  2011-12       Impact factor: 0.705

3.  Clinical pharmacology at the core of translational science.

Authors:  Scott A Waldman; Andre Terzic
Journal:  Expert Rev Clin Pharmacol       Date:  2011-05       Impact factor: 5.045

4.  Advances in cardiac ATP-sensitive K+ channelopathies from molecules to populations.

Authors:  Andre Terzic; Alexey E Alekseev; Satsuki Yamada; Santiago Reyes; Timothy M Olson
Journal:  Circ Arrhythm Electrophysiol       Date:  2011-08
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.